SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
A medic holds up a vial of the Covishield Covid-19 vaccine at Balrampur Hospital, on January 16, 2021 in Lucknow, India. (Photo: Deepak Gupta/Hindustan Times via Getty Images)
'Deeply Alarming': AstraZeneca Charging South Africa More Than Double What Europeans Pay for Covid-19 Vaccine
"This is the problem when you have essential medicines in the hands of big business, with almost no transparency as to pricing."
Jan 21, 2021
"The unfair patent system is now one the biggest obstacles to defeating this virus."
That was the core critique from Nick Dearden, executive director of the U.K.-based advocacy group Global Justice Now, on Friday morning in response to news this week that South Africa is paying more than double for AstraZeneca's Covid-19 vaccine compared to most countries in Europe.
According to a report by The Guardian, a Belgian minister leaked information revealing that European Union members are paying EUR1.78 ($2.16) per dose for the AstraZeneca vaccine. Meanwhile, even as the pharmaceutical giant has said it would cap the price at EUR2.50 (approx. $3) per dose, South Africa's deputy director general of health Anban Pillay confirmed to the newspaper that it was quoted a price of $5.25 per dose.
"The explanation we were given for why other high-income countries have a lower price is that they have invested in the [research and development], hence the discount on the price," Pillay told Business Day.
As Global Justice Now noted in a statement, the Thursday's news from South Africa came the same day it was revealed that the World Health Organization (WHO) initiative "to share the science and know-how for coronavirus medicines had received no contributions"--a disappointing outcome that campaigners said was the result of a kind of joint boycott by Big Pharma and wealthy governments.
"South Africa's desperate predicament is a symptom of the shocking failure of rich countries to deal with this virus in a fair and effective manner," said Dearden in his statement. "Like many African countries, cases are soaring in South Africa, yet many countries will find a European-style lockdown impossible. As cases spread, mutations will continue to manifest and threaten all of our efforts to contain this disease."
\u201cCrystal clear explanation from @nickdearden75 about the dangers and injustice of vaccinating whole populations of rich nations before protecting the most vulnerable in every country. Vaccines are publicly funded and govts need to break monopolies so they reach everyone everywhere\u201d— Heidi Chow (@Heidi Chow) 1611232369
While pointing a finger at the global patent system which allows drug corporations to prevent mass production of generic alternatives and the sharing of life-saving technology, Dearden said the situation in South Africa exemplifies the injustice that is being felt--and will continue to be felt--when the people in poorer or less-developed nations are treated as second-class humans compared to their more wealthy counterparts.
"We are calling on AstraZeneca to explain how this pricing has happened, given their promise to cap charges," said Dearden. "This is the problem when you have essential medicines in the hands of big business, with almost no transparency as to pricing. We urgently need technology and patents placed in public hands so we can share this knowledge and produce more vaccines now. Our ability to defeat this virus fairly and effectively depends upon it."
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
"The unfair patent system is now one the biggest obstacles to defeating this virus."
That was the core critique from Nick Dearden, executive director of the U.K.-based advocacy group Global Justice Now, on Friday morning in response to news this week that South Africa is paying more than double for AstraZeneca's Covid-19 vaccine compared to most countries in Europe.
According to a report by The Guardian, a Belgian minister leaked information revealing that European Union members are paying EUR1.78 ($2.16) per dose for the AstraZeneca vaccine. Meanwhile, even as the pharmaceutical giant has said it would cap the price at EUR2.50 (approx. $3) per dose, South Africa's deputy director general of health Anban Pillay confirmed to the newspaper that it was quoted a price of $5.25 per dose.
"The explanation we were given for why other high-income countries have a lower price is that they have invested in the [research and development], hence the discount on the price," Pillay told Business Day.
As Global Justice Now noted in a statement, the Thursday's news from South Africa came the same day it was revealed that the World Health Organization (WHO) initiative "to share the science and know-how for coronavirus medicines had received no contributions"--a disappointing outcome that campaigners said was the result of a kind of joint boycott by Big Pharma and wealthy governments.
"South Africa's desperate predicament is a symptom of the shocking failure of rich countries to deal with this virus in a fair and effective manner," said Dearden in his statement. "Like many African countries, cases are soaring in South Africa, yet many countries will find a European-style lockdown impossible. As cases spread, mutations will continue to manifest and threaten all of our efforts to contain this disease."
\u201cCrystal clear explanation from @nickdearden75 about the dangers and injustice of vaccinating whole populations of rich nations before protecting the most vulnerable in every country. Vaccines are publicly funded and govts need to break monopolies so they reach everyone everywhere\u201d— Heidi Chow (@Heidi Chow) 1611232369
While pointing a finger at the global patent system which allows drug corporations to prevent mass production of generic alternatives and the sharing of life-saving technology, Dearden said the situation in South Africa exemplifies the injustice that is being felt--and will continue to be felt--when the people in poorer or less-developed nations are treated as second-class humans compared to their more wealthy counterparts.
"We are calling on AstraZeneca to explain how this pricing has happened, given their promise to cap charges," said Dearden. "This is the problem when you have essential medicines in the hands of big business, with almost no transparency as to pricing. We urgently need technology and patents placed in public hands so we can share this knowledge and produce more vaccines now. Our ability to defeat this virus fairly and effectively depends upon it."
"The unfair patent system is now one the biggest obstacles to defeating this virus."
That was the core critique from Nick Dearden, executive director of the U.K.-based advocacy group Global Justice Now, on Friday morning in response to news this week that South Africa is paying more than double for AstraZeneca's Covid-19 vaccine compared to most countries in Europe.
According to a report by The Guardian, a Belgian minister leaked information revealing that European Union members are paying EUR1.78 ($2.16) per dose for the AstraZeneca vaccine. Meanwhile, even as the pharmaceutical giant has said it would cap the price at EUR2.50 (approx. $3) per dose, South Africa's deputy director general of health Anban Pillay confirmed to the newspaper that it was quoted a price of $5.25 per dose.
"The explanation we were given for why other high-income countries have a lower price is that they have invested in the [research and development], hence the discount on the price," Pillay told Business Day.
As Global Justice Now noted in a statement, the Thursday's news from South Africa came the same day it was revealed that the World Health Organization (WHO) initiative "to share the science and know-how for coronavirus medicines had received no contributions"--a disappointing outcome that campaigners said was the result of a kind of joint boycott by Big Pharma and wealthy governments.
"South Africa's desperate predicament is a symptom of the shocking failure of rich countries to deal with this virus in a fair and effective manner," said Dearden in his statement. "Like many African countries, cases are soaring in South Africa, yet many countries will find a European-style lockdown impossible. As cases spread, mutations will continue to manifest and threaten all of our efforts to contain this disease."
\u201cCrystal clear explanation from @nickdearden75 about the dangers and injustice of vaccinating whole populations of rich nations before protecting the most vulnerable in every country. Vaccines are publicly funded and govts need to break monopolies so they reach everyone everywhere\u201d— Heidi Chow (@Heidi Chow) 1611232369
While pointing a finger at the global patent system which allows drug corporations to prevent mass production of generic alternatives and the sharing of life-saving technology, Dearden said the situation in South Africa exemplifies the injustice that is being felt--and will continue to be felt--when the people in poorer or less-developed nations are treated as second-class humans compared to their more wealthy counterparts.
"We are calling on AstraZeneca to explain how this pricing has happened, given their promise to cap charges," said Dearden. "This is the problem when you have essential medicines in the hands of big business, with almost no transparency as to pricing. We urgently need technology and patents placed in public hands so we can share this knowledge and produce more vaccines now. Our ability to defeat this virus fairly and effectively depends upon it."
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.